Literature DB >> 12805189

ATAC trial: reporting interim results is not helpful.

Heather Goodare, Clare Dimmer, Kathy Page.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12805189      PMCID： PMC1126206          DOI： 10.1136/bmj.326.7402.1329-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Aromatase inhibitors for the endocrine adjuvant treatment of breast cancer.

Authors:  Peter Ravdin
Journal:  Lancet       Date:  2002-06-22       Impact factor: 79.321

2.  Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.

Authors:  M Baum; A U Budzar; J Cuzick; J Forbes; J H Houghton; J G M Klijn; T Sahmoud
Journal:  Lancet       Date:  2002-06-22       Impact factor: 79.321

3.  Survival of patients with breast cancer attending Bristol Cancer Help Centre.

Authors:  F S Bagenal; D F Easton; E Harris; C E Chilvers; T J McElwain
Journal:  Lancet       Date:  1990-09-08       Impact factor: 79.321
  3 in total
  1 in total

1.  ATAC trial did not report interim results.

Authors:  Michael Baum; Aman Buzdar; Anthony Howell
Journal:  BMJ       Date:  2003-11-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.